The AIR-1 gene product CIITA is the master regulator of MHC class II gene expression. This makes CIITA a crucial element for triggering antigen presentation to CD4+ T cells and thus the cascade of events leading to an efficient adaptive immune response. Recently we discovered that CIITA is also endowed with the capacity to directly inhibit both HIV-1 and HTLV retroviruses in infected cells by blocking the function of the viral transactivators Tat and Tax. Thus CIITA exerts a dual role against human retroviruses. The first, classical role is the upregulation of MHC class II expression and thus the capacity to present viral antigens to CD4+ T cells. The other, evolutionary new and fundamental role is to inhibit directly viral replication and spreading. We will discuss the molecular mechanisms by which CIITA counteracts specifically viral transactivators. These distinct properties of CIITA will shed new light on the molecular mechanisms of adaptive coevolution of hosts and pathogens and may be exploited to envisage novel therapeutic strategies aimed at counteracting retroviral infections and thus their oncogenic potential.

The dual function of the MHC class II against human oncogenic retroviruses

TOSI, GIOVANNA;ACCOLLA, ROBERTO
2009-01-01

Abstract

The AIR-1 gene product CIITA is the master regulator of MHC class II gene expression. This makes CIITA a crucial element for triggering antigen presentation to CD4+ T cells and thus the cascade of events leading to an efficient adaptive immune response. Recently we discovered that CIITA is also endowed with the capacity to directly inhibit both HIV-1 and HTLV retroviruses in infected cells by blocking the function of the viral transactivators Tat and Tax. Thus CIITA exerts a dual role against human retroviruses. The first, classical role is the upregulation of MHC class II expression and thus the capacity to present viral antigens to CD4+ T cells. The other, evolutionary new and fundamental role is to inhibit directly viral replication and spreading. We will discuss the molecular mechanisms by which CIITA counteracts specifically viral transactivators. These distinct properties of CIITA will shed new light on the molecular mechanisms of adaptive coevolution of hosts and pathogens and may be exploited to envisage novel therapeutic strategies aimed at counteracting retroviral infections and thus their oncogenic potential.
2009
Tosi, Giovanna; Bozzo, L; Accolla, Roberto
File in questo prodotto:
File Dimensione Formato  
Tosi 3.pdf

non disponibili

Tipologia: Documento in Post-print
Licenza: DRM non definito
Dimensione 231.68 kB
Formato Adobe PDF
231.68 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Scheda Tosi 3.doc

non disponibili

Tipologia: Altro materiale allegato
Licenza: DRM non definito
Dimensione 27.5 kB
Formato Microsoft Word
27.5 kB Microsoft Word   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11383/1715166
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 9
  • ???jsp.display-item.citation.isi??? 8
social impact